We deliver our long-term priorities of Innovation, Performance and Trust
through each of our three businesses which discover, develop and manufacture innovative
pharmaceutical medicines, vaccines and consumer healthcare products. Our approach to Pharmaceutical
Research and Development (R&D) focuses on science related to the immune system, the use of human
genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x
Culture. It will help us to accelerate the pace at which we develop and deliver transformational
medicines, prioritising those molecules with a higher probability of success and terminating less
promising programmes. It also enables us to increase our focus on specialty medicines in areas such
as oncology.
Our Innovation ambition is to lead the industry by disrupting the
discovery, development and manufacturing of life saving medicines. We will focus on accelerating key
assets in our pipeline and looking at innovative technologies so that we can unlock potential in
emerging fields. Using our industry-leading science, we will accelerate the delivery of our most
promising assets to serve the greatest unmet medical need. We want to change the world with our
science. Our Consumer Healthcare R&D organisation develops products in five categories: Oral Health,
Pain Relief, Respiratory,Cardiology ,Neurology Nutrition and Gastrointestinal and Skin Health. Our
focus is on building a strong, competitive pipeline of consumer-led, science-based innovation.
Waiting for the Approval from the Department of Scientific and Industrial Research,
Government of India, it facilitates the development and quality up-gradation of safe and efficacious
formulations. With a team of over 1000+ researchers, scientists, IP and legal experts, we are
planning for approvals across markets in Europe, Malaysia, USA, South Africa, Brazil, etc to spread
our wings globally.
The R&D Centre comprises of individual departments that focus on a variety of developmental activities: